222 related articles for article (PubMed ID: 17049803)
1. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.
Wilson HK; Cox DJ; Merkel RL; Moore M; Coghill D
Arch Clin Neuropsychol; 2006 Dec; 21(8):797-807. PubMed ID: 17049803
[TBL] [Abstract][Full Text] [Related]
2. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
3. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
4. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
5. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
Coghill DR; Rhodes SM; Matthews K
Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
[TBL] [Abstract][Full Text] [Related]
6. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
Pearson DA; Santos CW; Casat CD; Lane DM; Jerger SW; Roache JD; Loveland KA; Lachar D; Faria LP; Payne CD; Cleveland LA
J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):677-85. PubMed ID: 15167084
[TBL] [Abstract][Full Text] [Related]
7. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
Cox DJ; Merkel RL; Penberthy JK; Kovatchev B; Hankin CS
J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):269-75. PubMed ID: 15076259
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
9. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
10. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence.
Smith BH; Pelham WE; Gnagy E; Yudell RS
J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):314-21. PubMed ID: 9519637
[TBL] [Abstract][Full Text] [Related]
11. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
13. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
[TBL] [Abstract][Full Text] [Related]
14. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
McCracken JT; Biederman J; Greenhill LL; Swanson JM; McGough JJ; Spencer TJ; Posner K; Wigal S; Pataki C; Zhang Y; Tulloch S
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):673-83. PubMed ID: 12921475
[TBL] [Abstract][Full Text] [Related]
15. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate.
Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Kenemans JL; Camfferman G; Buitelaar JK; Koelega HS
Psychophysiology; 1999 Jul; 36(4):419-29. PubMed ID: 10432791
[TBL] [Abstract][Full Text] [Related]
16. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
Rostain AL
Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
[TBL] [Abstract][Full Text] [Related]
17. Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD.
Brown TE; Landgraf JM
Postgrad Med; 2010 Sep; 122(5):42-51. PubMed ID: 20861587
[TBL] [Abstract][Full Text] [Related]
18. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
Bental B; Tirosh E
J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
20. Adderall XR: long acting stimulant for single daily dosing.
Sallee FR; Smirnoff AV
Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]